Teleflex Inc 8-K Filing

FAQ

Key Financial Figures

• $1 — ich registered Common Stock, par value $1 per share TFX New York Stock Exchan
• $1,500,000,000 — EM Business "), for a purchase price of $1,500,000,000 in cash (the " OEM Purchase Price "), s
• $90,000,000 — to pay the Company a termination fee of $90,000,000. The transaction is expected to be comp
• $530,000,000 — gy Business "), for a purchase price of $530,000,000 in cash (the " Acute Care and Urology P
• $1 billion — ed a share repurchase program for up to $1 billion of the Company's common stock. The prog

Filing Documents

• d30566d8k.htm (8-K) — 44KB
• d30566dex21.htm (EX-2.1) — 642KB
• d30566dex22.htm (EX-2.2) — 610KB
• d30566dex991.htm (EX-99.1) — 13KB
• g30566teleflex.jpg (GRAPHIC) — 6KB
• 0001193125-25-312941.txt ( ) — 1739KB
• tfx-20251209.xsd (EX-101.SCH) — 3KB
• tfx-20251209_lab.xml (EX-101.LAB) — 18KB
• tfx-20251209_pre.xml (EX-101.PRE) — 11KB
• d30566d8k_htm.xml (XML) — 4KB

Forward-Looking Statements

Forward-Looking Statements Certain statements made in this Current Report on Form 8-K, other than statements of historical fact, are forward-looking statements. The words "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "will," "would," "should," "guidance," "potential," "continue," "project," "forecast," "confident," "prospects" and similar expressions typically are used to identify forward-looking statements. These statements include, but are not limited to, statements related to the transactions, regulatory approvals and the expected timing of the closing of the transactions. Forward-looking statements are based on the then-current expectations, beliefs, assumptions, estimates and forecasts about the Company's business and the industry and markets in which the Company operates. These statements are not guarantees of future performance and are subject to risks and uncertainties, which are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied by these forward-looking statements due to a number of factors, including changes in business relationships with and purchases by or from major customers or suppliers; delays or cancellations in shipments; demand for and market acceptance of new and existing products; the impact of inflation and disruptions in the Company's global supply chain on the Company and its suppliers (particularly sole-source suppliers and providers of sterilization services), including fluctuations in the cost and availability of resins and other raw materials, as well as certain components, used in the production or sterilization of the Company's products, transportation constraints and delays, product shortages, energy shortages or increased energy costs, labor shortages in the United States and elsewhere, and increased operating and labor costs; the Company's inability to integrate acquired businesses into its operations, realize planned synergies and operate s

View Full Filing

View this 8-K filing on SEC EDGAR